Musculo-skeletal disorders, Guidance

Applied filters

Care Setting (1)
- Primary Care and PCNs (1)
- Trusts (1)
Guidance (73)
- Dosing (2)
- Safety in Breastfeeding (66)
- Temperature management (19)
  - Stability outside the fridge (19)
Medicine (73)
- Abatacept (1)
- Aceclofenac (1)
- Acemetacin (1)
- Adalimumab (1)
- Alendronic acid (2)
- Allopurinol (2)
- Azathioprine (1)
- Baclofen (1)
- Belimumab (1)
- Bimekizumab (1)
- Calcitonin (2)
- Canakinumab (2)
- Capsaicin (2)
- Celecoxib (1)
- Certolizumab pegol (1)
- Chloroquine (1)
- Ciclosporin (1)
- Colchicine (2)
- Collagenase clostridium histolyticum (2)
- Dantrolene (1)
- Denosumab (2)
- Dexketoprofen (1)
- Diazepam (1)
- Diclofenac sodium (2)
- Dronabinol + Cannabidiol (1)
- Eculizumab (1)
- Edrophonium (1)
- Etanercept (1)
- Etidronate disodium (2)
- Etodolac (1)
- Etoricoxib (1)
- Fampridine (1)
- Febuxostat (2)
- Felbinac (2)
- Flurbiprofen (1)
- Glucosamine sulfate (1)
- Golimumab (1)
- Hydroxychloroquine (1)
- Ibuprofen (2)
- Indometacin (1)
- Infliximab (1)
- Kaolin (2)
- Ketoprofen (2)
- Leflunomide (1)
- Mefenamic acid (1)
- Meloxicam (1)
- Methocarbamol (1)
- Methotrexate (2)
- Mexiletine (1)
- Nabumetone (1)
- Naltrexone (1)
- Naproxen (1)
- Neostigmine (1)
- Ofatumumab (1)
- Penicillamine (1)
- Piroxicam (2)
- Probenecid (2)
- Pyridostigmine (1)
- Quinine (1)
- Rasburicase (2)
- Risedronate sodium (2)
- Rituximab (1)
- Sodium picosulfate (1)
- Sulfasalazine (1)
- Sulfinpyrazone (2)
- Teriparatide (1)
- Tizanidine (1)
- Tocilizumab (1)
- Triamcinolone acetonide (1)
Medicines planning (31)
- New Medicines (20)
  - CCG commissioned new medicines (10)
  - NHS England commissioned new medicines (10)
  - Pre-registration new medicines (UK/EU) (3)
- Patent expiries (23)
Specialty (73)
- Allergy and immunology (4)
- Anaesthesia and pain (22)
- Cancers (8)
- Cardiovascular system disorders (2)
- Ear, nose and throat disorders (1)
- Endocrine system disorders (4)
- Eyes and vision (5)
- Gastrointestinal disorders (6)
- Haematological disorders (2)
- Infection and infectious diseases (4)
- Mental health and illness (1)
- Musculo-skeletal disorders (73)
- Neurological disorders (3)
- Skin disorders (9)

Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief

28 October 2020Topical formulations of non-steroidal anti-inflammatories (NSAIDS) and capsaicin produce low systemic levels in the mother. Although there is no direct evidence, subsequent milk levels are…

Safety in Lactation: Gout and cytotoxic-induced hyperuricaemia

21 October 2020Colchicine and canakinumab are normally used to treat the symptoms of acute attacks of gout. Allopurinol, febuxostat and sulfinpyrazone are used for the long-term control…

Safety in Lactation: Drugs affecting bone metabolism

18 September 2020Drugs used exclusively for postmenopausal osteoporosis have not been included. Bisphosphonates have very poor oral bioavailability in fasting adults, which is decreased even further in…

What is the evidence for low dose naltrexone for treatment of multiple sclerosis?

11 February 2020This updated Medicines Q&A evaluates the limited evidence available for low dose naltrexone for treatment of multiple sclerosis.

SPS - Specialist Pharmacy Service

NHS

Musculo-skeletal disorders, Guidance

73 results

Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief

Safety in Lactation: Gout and cytotoxic-induced hyperuricaemia

Safety in Lactation: Drugs affecting bone metabolism

What is the evidence for low dose naltrexone for treatment of multiple sclerosis?

Bimekizumab

Adalimumab

Infliximab

Etanercept

Canakinumab

Denosumab

Learn more about us or ask for help

Medicines Tools